Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
HIT Consultant
NOVEMBER 30, 2022
a power Visa and ultimately the government could not deny. When a consumer transfers funds electronically from one financial platform to another, or makes a deposit, or applies for a mortgage, there’s a decent chance Plaid is involved. A similar inflection point now faces the specialty pharmaceutical industry.
98 
Let's personalize your content